检查结果： 1.没有书面评价，这是好的情况； 2.轻微项的483表，或一封感谢信； 3.有批评的483表，它可能会导致：1）Seizure（查封）2）Detention(扣押)3）Restraining Orders and Injunctions(强制停产)4）Penalties（罚款）5）Recall（撤回） 4. Waring letter（警告信）审核重点：对于不同的产品，审核的重点不一样的
QSR820的要求 QSR820的要求分为7个子体系，分别是：管理控制、纠正和预防措施（CAPA）（具有的器械报告系统、纠正和移除系统、器械记录系统）、设计控制、生产和过程控制（P&PC）（具有的灭菌过程控制系统）、设备设施控制、材料控制以及文件记录和变更控制。
FDA对于美国代理人的解释也可以参考看一下网站的原文： Any foreign establishment engaged in the manufacture, preparation, propagation, compounding, or processing of a device imported into the United States must identify a United States agent (U.S. agent) for that establishment. Information about a foreign establishment’s U.S. Agent is submitted electronically using the FDA Unified Registration and Listing System (FURLS system) and is part of the establishment registration process. Each foreign establishment may designate only one U.S. agent. The foreign establishment may also, but is not required to, designate its U.S. agent as its official correspondent. The foreign establishment should provide the name, address, telephone and fax numbers, and e-mail address of the U.S. agent. The U.S. agent identified will be required to complete an automated process to confirm that they have agreed to act as the U.S. agent. The automated process will forward an email verification request to the U.S. agent. They will be requested to confirm her/his consent to act as a representative/liaison on behalf of the foreign establishment. If the U.S. agent denies consent (or does not respond within 10 business days), the Official Correspondent/Owner Operator of the foreign establishment will be notified and must designate a new U.S. agent to satisfy the regulatory obligation.
提供FDA注册，食品FDA注册、化妆品FDA注册，美国代理人服务、FDA验厂、FDA警告性移除